Role for basophils in systemic anaphylaxis

Chemical Immunology and Allergy

Volumn 95, Issue , 2010, Pages 85-97

  Karasuyama, Hajime ^a   Tsujimura, Yusuke ^a,b   Obata, Kazushige ^a   Mukai, Kaori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ALLERGY; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANTIGEN PRESENTATION; BASOPHIL; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOREGULATION; IN VIVO STUDY; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; TH2 CELL;

ANAPHYLAXIS; ANIMALS; BASOPHILS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOGLOBULIN G; PLATELET ACTIVATING FACTOR;

EID: 77954835788     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000315939     Document Type: Review

References (49)

1. Galli SJ: Mast cells and basophils. Curr Opin Hematol 2000;7:32-39.
2. Prussin C, Metcalfe DD: 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2003;111:S486-S494.
3. Falcone FH, Haas H, Gibbs BF: The human basophil: a new appreciation of its role in immune responses. Blood 2000;96:4028-4038.
4. Arock M, Schneider E, Boissan M, Tricottet V, Dy M: Differentiation of human basophils: an overview of recent advances and pending questions. J Leukoc Biol 2002;71:557-564.
5. Arinobu Y, Iwasaki H, Gurish MF, Mizuno S, Shigematsu H, Ozawa H, Tenen TG, Austen KF, Akashi K: Developmental checkpoints of the basophil/ mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA 2005;102:18105-18110.
6. Jones TD, Mote JR: The phases of foreign protein sensitization in human beings. N Engl J Med 1934; 210:120-123.
7. Richerson HB, Dvorak HF, Leskowitz S: Cutaneous basophil hypersensitivity. I. A new look at the Jones-Mote reaction, general characteristics. J Exp Med 1970;132:546-557.
8. Dvorak HF, Dvorak AM, Simpson BA, Richerson HB, Leskowitz S, Karnovsky MJ: Cutaneous basophil hypersensitivity. II. A light and electron microscopic description. J Exp Med 1970;132:558-582.
9. Allen JR: Tick resistance: basophils in skin reactions of resistant guinea pigs. Int J Parasitol 1973;3:195-200.
10. Brown SJ, Galli SJ, Gleich GJ, Askenase PW: Ablation of immunity to Amblyomma americanum by antibasophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol 1982;129:790-796.
11. Dvorak AM: The mouse basophil, a rare and rarely recognized granulocyte. Blood 2000;96:1616-1617.
12. Voehringer D, Shinkai K, Locksley RM: Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 2004;20: 267-277.
13. Mack M, Schneider MA, Moll C, Cihak J, Bruhl H, Ellwart JW, Hogarth MP, Stangassinger M, Schlondorff D: Identification of antigen-capturing cells as basophils. J Immunol 2005;174:735-741.
14. Kojima T, Obata K, Mukai K, Sato S, Takai T, Minegishi Y, Karasuyama H: Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-independent manner. J Immunol 2007;179:7093-7100.
15. Schroeder JT, MacGlashan DW Jr, Lichtenstein LM: Human basophils: mediator release and cytokine production. Adv Immunol 2001;77:93-122.
16. Seder RA, Paul WE, Dvorak AM, Sharkis SJ, Kagey-Sobotka A, Niv Y, Finkelman FD, Barbieri SA, Galli SJ, Plaut M: Mouse splenic and bone marrow cell populations that express high-affinity Fc ε receptors and produce interleukin-4 are highly enriched in basophils. Proc Natl Acad Sci USA 1991;88:2835-2839.
17. Min B, Prout M, Hu-Li J, Zhu J, Jankovic D, Morgan ES, Urban JF Jr, Dvorak AM, Finkelman FD, LeGros G, Paul WE: Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med 2004;200:507-517.
18. Min B, Paul WE: Basophils and type 2 immunity. Curr Opin Hematol 2008;15:59-63.
19. Mukai K, Matsuoka K, Taya C, Suzuki H, Yokozeki H, Nishioka K, Hirokawa K, Etori M, Yamashita M, Kubota T, Minegishi Y, Yonekawa Y, Karasuyama H: Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005; 23:191-202.
20. Obata K, Mukai K, Tsujimura Y, Ishiwata K, Kawano Y, Minegishi Y, Watanabe N, Karasuyama H: Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 2007;110:913-920.
21. Sokol CL, Barton GM, Farr AG, Medzhitov R: A mechanism for the initiation of allergen-induced T-helper type 2 responses. Nat Immunol 2008;9:310-318.
22. Denzel A, Maus UA, Rodriguez Gomez M, Moll C, Niedermeier M, Winter C, Maus R, Hollingshead S, Briles DE, Kunz-Schughart LA, Talke Y, Mack M: Basophils enhance immunological memory responses. Nat Immunol 2008;9:733-742.
23. Tsujimura Y, Obata K, Mukai K, Shindou H, Yoshida M, Nishikado H, Kawano Y, Minegishi Y, Shimizu T, Karasuyama H: Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 2008;28:581-589.
24. Min B: Basophils: what they 'can do' versus what they 'actually do'. Nat Immunol 2008;9:1333-1339.
25. Karasuyama H, Mukai K, Tsujimura Y, Obata K: Newly discovered roles for basophils: a neglected minority gains new respect. Nat Rev Immunol 2009; 9:9-13.
26. Hida S, Tadachi M, Saito T, Taki S: Negative control of basophil expansion by IRF-2 critical for the regulation of Th1/Th2 balance. Blood 2005;106:2011-2017.
27. Oh K, Shen T, Le Gros G, Min B: Induction of Th2 type immunity in a mouse system reveals a novel immunoregulatory role of basophils. Blood 2007; 109:2921-2927.
28. Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, Medzhitov R: Basophils function as antigen-presenting cells for an allergen-induced T-helper type 2 response. Nat Immunol 2009;10:713-720.
29. Yoshimoto T, Yasuda K, Tanaka H, Nakahira M, Imai Y, Fujimori Y, Nakanishi K: Basophils contribute to TH2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol 2009; 10:706-712.
30. Perrigoue JG, Saenz SA, Siracusa MC, Allenspach EJ, Taylor BC, Giacomin PR, Nair MG, Du Y, Zaph C, van Rooijen N, Comeau MR, Pearce EJ, Laufer TM, Artis D: MHC class II-dependent basophil-CD4+ T-cell interactions promote TH2 cytokinedependent immunity. Nat Immunol 2009;10: 697-705.
31. Galli SJ: Pathogenesis and management of anaphylaxis: current status and future challenges. J Allergy Clin Immunol 2005;115:571-574.
32. Bochner BS, Lichtenstein LM: Anaphylaxis. N Engl J Med 1991;324:1785-1790.
33. Kemp SF, Lockey RF: Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002;110:341-348.
34. Jacoby W, Cammarata PV, Findlay S, Pincus SH: Anaphylaxis in mast cell-deficient mice. J Invest Dermatol 1984;83:302-304.
35. Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P: Active anaphylaxis in IgEdeficient mice. Nature 1994;370:367-370.
36. Finkelman FD: Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 2007;120:506-515.
37. Dombrowicz D, Flamand V, Miyajima I, Ravetch JV, Galli SJ, Kinet JP: Absence of FcγRI α chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcεRI and FcεRIII for limiting amounts of FcR β and γ chains. J Clin Invest 1997; 99:915-925.
38. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ: Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE-or IgG1-dependent passive anaphylaxis. J Clin Invest 1997;99:901-914.
39. Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD: Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 2002;109:658-668.
40. Hirayama N, Hirano T, Kohler G, Kurata A, Okumura K, Ovary Z: Biological activities of antitrinitrophenyl and antidinitrophenyl mouse monoclonal antibodies. Proc Natl Acad Sci USA 1982;79: 613-615.
41. Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, Schmidt RE, Sandor M, Capel PJ, Daeron M, van de Winkel JG, Verbeek JS: Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16)-deficient mice. Immunity 1996;5:181-188.
42. Arimura A, Nagata M, Takeuchi M, Watanabe A, Nakamura K, Harada M: Active and passive cutaneous anaphylaxis in WBB6F1 mouse, a mast celldeficient strain. Immunol Invest 1990;19:227-233.
43. Cheifetz A, Smedley M, Martin S, Reiter M, Leone G, Mayer L, Plevy S: The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol 2003;98:1315-1324.
44. Dybendal T, Guttormsen AB, Elsayed S, Askeland B, Harboe T, Florvaag E: Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia. Acta Anaesthesiol Scand 2003;47:1211-1218.
45. Adourian U, Shampaine EL, Hirshman CA, Fuchs E, Adkinson NF Jr: High-titer protamine-specific IgG antibody associated with anaphylaxis: report of a case and quantitative analysis of antibody in vasectomized men. Anesthesiology 1993;78:368-372.
46. Kraft D, Hedin H, Richter W, Scheiner O, Rumpold H, Devey ME: Immunoglobulin class and subclass distribution of dextran-reactive antibodies in human reactors and non-reactors to clinical dextran. Allergy 1982;37:481-489.
47. Weiss M, Nyhan ED, Peng JK, Horrow JC, Lowenstein E, Hirshman C, Adkinson NF Jr: Association of protamine IgE and IgG antibodies with lifethreatening reactions to intravenous protamine. N Engl J Med 1989;320:886-892.
48. Lie WJ, Homburg CH, Kuijpers TW, Knol EF, Mul FP, Roos D, Tool AT: Regulation and kinetics of platelet-activating factor and leukotriene C4 synthesis by activated human basophils. Clin Exp Allergy 2003;33:1125-1134.
49. Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, Simons FE, Simons JK, Cass D, Yeung J: Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008;358:28-35.